With the lingering covid cases and waning protection of mRNA vaccines, what do you guys think the role Novavax has in the covid market. Their earnings show a promising future and they just added an independent BOD that has extensive experience in company acquisitions.
The low float and super high short interest the stock has also makes me think that a massive short squeeze is inevitable. Looking at the company's chart dating back to the late 90s, convinces me that with a product and other vaccines in a pipeline, it's a matter of when not if. What's everyone's take on this?
I do have a long position and doesn't want to sell too early of a massive short squeeze is on its way.
Leave a Reply